"We are on the verge of a revolution in medicine: understanding, treating, and ultimately preventing the causes of degenerative aging. But medical revolutions only happen if we all stand up in support of funding and research. We did it for cancer. We're doing it for Alzheimer's. We can do it for aging - and create an era of longer, healthier lives!"

  
Search

Required Reading
Activism and Advocacy
Calorie Restriction
The Community, Visualized
Cryonics
Envisaging a World Without the FDA
Healthy Life Extension Explained
Introductory Articles
Longevity Meme Newsletter
The Most Important Debate
Stem Cells, Regenerative Medicine
SENS, Negligible Senescence
What is Anti-Aging?

Initiatives
Biogerontology Research Foundation
LifeStar Institute
Methuselah Foundation
Mprize for Longevity Research
Science Against Aging (Translate)
SENS Foundation

On the Causes of Aging
Accumulating AGEs
The Failing Immune System
Junk in the Lysosome
Mitochondrial Free Radicals
Senescent Cells
Other Causes of Aging

Benefiting From Medical Research
How to Read Scientific Research
Researching Therapies and Clinical Trials

Objections Answered
Boredom
Inequality and Economics
Overpopulation
Stagnation
Being Older for Longer?
What About Retirement?

Recent Entries

  • Subtleties of Calorie Restriction and Evolution
  • Signs of the Times: Engineered Organs in the Popular Press
  • Genescient Envisioned as Sirtris++
  • Help the Immortality Institute Fund Research Into Laser Ablation of Lipofuscin
  • The Singularity's Time in the Sun
  • Deciphering the Machine By Pulling Out Cogs and Flipping Switches
  • Scientific American on Alzheimer's Research
  • The Downward Spiral
  • A Male-Only Longevity Mutation in Mice
  • Cryonics and Economic Incentives
  • Bid in a Charity Auction For a Portrait of Aubrey de Grey
  • You Have To Do Better Than That
  • Failing Memory and the Failing Immune System: Reversible?
  • A New Spanner to Throw Into the Works of Cancer
  • The Benefits of Falling Costs in Biotechnology
  • SENS 4: Early Registration and Abstract Submission Deadline Approaches
  • A Cautionary Tale and a Point of Principle
  • On the 2009 AGE Conference
  • An Update on Decellularization / Recellularization
  • Accumulating Mitochondrial DNA Damage: More Harm or Less Repair?

    Blogs of Interest
    Accelerating Future
    Ageing Research
    Anti-Ageing Research
    Alcor News
    Al Fin Longevity
    April's CR Diary
    Andart
    Biosingularity
    CRON Diary
    Cryonics Society
    Depressed Metabolism
    Distributed Republic
    Ethical Technology Blog
    Existence is Wonderful
    Future Current
    FuturePundit
    grailsearch.org
    green light go
    In Search of Enlightenment
    Longevity Science
    Marginal Revolution
    Metamagician and the Hellfire Club
    Metamodern
    Methuselah Foundation Blog
    Mises Economics Blog
    Nanodot
    Ouroboros
    Overcoming Bias
    Pimm - Partial immortalization
    Responsible Nanotechnology
    ScienceBlogs
    Sentient Developments
    Singularity Hub
    Singularity Institute Blog
    The Loom
    The Speculist
    Transumanar

    Archives (Monthly)

    July 2009
    June 2009
    May 2009
    April 2009
    March 2009
    February 2009
    January 2009
    December 2008
    November 2008
    October 2008
    September 2008
    August 2008
    July 2008
    June 2008
    May 2008
    April 2008
    March 2008
    February 2008
    January 2008
    December 2007
    November 2007
    October 2007
    September 2007
    August 2007
    July 2007
    June 2007
    May 2007
    April 2007
    March 2007
    February 2007
    January 2007
    December 2006
    November 2006
    October 2006
    September 2006
    August 2006
    July 2006
    June 2006
    May 2006
    April 2006
    March 2006
    February 2006
    January 2006
    December 2005
    November 2005
    October 2005
    September 2005
    August 2005
    July 2005
    June 2005
    May 2005
    April 2005
    March 2005
    February 2005
    January 2005
    December 2004
    November 2004
    October 2004
    September 2004
    August 2004
    July 2004
    June 2004
    May 2004
    April 2004
    March 2004
    February 2004
    January 2004

    Creative Commons License
    Attribution, noncommercial, no derivative works. Play nice.

  • Thursday, October 18, 2007

    A Few Thoughts on the Funding of Aging Research

    Yesterday I stumbled onto a press release on the topic of funding from the Ellison Medical Foundation and the American Federation for Aging Research. I am very struck by the tone of the piece:

    The Ellison Medical Foundation has awarded AFAR more than $2.8 million to support 45 postdoctoral fellows (both MDs and PhDs at any level of postdoctoral training) over the next three years in the fundamental mechanisms of aging. With this new commitment, the Ellison Medical Foundation/AFAR partnership has increased five-fold the number of researchers it will support.

    ...

    There are so many promising scientists yet we are only able to fund eight percent of the applicants who seek grants. There's a potential to lose a tremendous brain trust of future leaders in aging research. The Ellison Medical Foundation has taken a lead role in helping the next generation of researchers establish careers and an aging society will benefit

    ...

    In the face of this opportunity we currently see declining federal support for scientists. Those just beginning their careers are especially vulnerable as support dries up. Our hope is that this decline is temporary, yet even a temporary reduction in support for scientists just beginning their careers, or those deciding whether to stay in science or build a career elsewhere, could result in the loss of most of a whole generation of scientists.

    ...

    "While AFAR-supported grant programs have traditionally focused on early-career scientists, it is also important to sustain that investment in our scientists at all stages of their careers," said Stephanie Lederman. This generous grant can make all the difference in allowing years of painstaking research to continue."

    "Mid-career scientists, with newly acquired tenure, are at a unique career stage. Freed from worry about getting tenure and job stability, they have more intellectual freedom than they have ever had before. We hope to empower them to try riskier research with great potential pay-off, for themselves and for an aging society."

    This might as well be language lifted from a mythical government release on the Full Employment Act for Gerontologists. It's all so grey and tired - rescue the scientists, pay the scientists, help the scientists. Note the utter absence of any sort of discussion of goals or results. What are these scientists actually doing? What is the value of it? Where are they going? When will they get there? What does it mean to me?

    This sort of thing is exactly why there is little public support for or understanding of mainstream aging research. I've long said that basic research is no different from any other human endeavor. It isn't magic, immune to planning - you can set goals, plans and schedules. You can invest in research in exactly the same way as commercial companies invest in research day in and day out. Those who claim that you can't set goals, timelines, explain matters to the public, create excitement and make real fireworks fly in an area of fundamental research are generally much more interested in the steady flow of dollars or their own particular hobby than in actually getting something meaningful accomplished.

    The drift of mainstream American science into government dependency has drained it of vigor and accountability to produce real progress. There's a reason why most of the interesting, productive scientists largely work outside that system, in the market or philanthropic ventures.

    Another thought: the languishing of aging science - in comparison to, say, regenerative medicine, tissue engineering or cancer research - makes $2.8 million a big deal. $10 million from the Glenn Foundation to establish the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging was a big splash in the pond.

    With those numbers for comparison, note that the Methuselah Foundation has $4.8 million pledged to Strategies for Engineered Negligible Senescence (SENS) research. I will venture to say that the Foundation has succeeded in building up to that level of funding by being everything that the Full Employment Act for Gerontologists is not. There is a plan, there are goals, there are timelines, there is accountability for failing to deliver - and a real effort to explain what all this work and funding really means to folk like you and I.

    Posted by Reason at October 18, 2007 7:27 PM | TrackBack (0)

    Posted by: Michael G.R. at October 21, 2007 1:53 PM

    Good post. I think you are spot on.

    If you don't inspire people and don't even try to explain why what you are working on is important an exciting, you can't expect people to support you.

    [Posted by: Michael G.R. at October 21, 2007 1:53 PM]

    Posted by: Tyciol at October 30, 2007 10:30 AM

    It does need to be jazzed up, but at the same time, basic statements like this are useful for people who do realize the implications, as I'm sure Reason does know. But yes, for public consumption, it needs fleshing out. Still, one doubts the common public reads such things, so complaints should be more focused on things more widespread.

    [Posted by: Tyciol at October 30, 2007 10:30 AM]

    Post a comment; thoughtful, considered opinions are valued. Please note that comments incorporating ad hominem attacks, advertising and other forms of inappropriate behavior are likely to be deleted.










    Remember personal info?